Guadalupe Ponciano-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guadalupe Ponciano-Rodríguez has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Nahum Méndez-Sánchez
Liver Research Unit, Medica Sur Clinic & Foundation and Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
5 shared publications - Mariana Michelle Ramírez-Mejía
Liver Research Unit, Medica Sur Clinic and Foundation, Mexico City 14050, Mexico; Plan of Combined Studies in Medicine (PECEM-MD/PhD), Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04360, Mexico
2 shared publications - Adriana Rocha-Camarena
Polithink. Ciudad de México, México...
1 shared publication - Alejandra Ramírez-Venegas
Research Department of COPD and Tobacco Smoking, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
1 shared publication - Alma Esperanza Ríos Ponce
Clínica Coyoacán
1 shared publication - Belen Saenz-De-Miera
Department of Economics, Autonomous University of Baja California Sur, La Paz, Mexico
1 shared publication
Latest Publications
- 21 November 2026
- Published by Elsevier in Archives of Medical Research
- Vol. 58 (2)
Hepatitis C Elimination in Latin America: Progress, Disparities, and Lessons for the Next Phase of Liver Health
- 21 November 2026
- Published by Elsevier in Archives of Medical Research
- Vol. 58 (2)
Hepatitis C Elimination in Latin America: Progress, Disparities, and Lessons for the Next Phase of Liver Health
- 30 January 2026
- Published by Elsevier in Archives of Medical Research
- Vol. 57 (4) , 103387
Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence
- 30 January 2026
- Published by Elsevier in Archives of Medical Research
- Vol. 57 (4) , 103387
Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence
- Open Access
- 14 January 2026
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 68 (1 (ene-feb) , 97-99
Bolsas de nicotina: la nueva amenaza de la industria tabacalera a la salud pública de México
- 14 January 2026
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 68 (1 (ene-feb) , 97-99
Open AccessBolsas de nicotina: la nueva amenaza de la industria tabacalera a la salud pública de México
- 3 November 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (8) , 103335
Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
- 3 November 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (8) , 103335
Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
- 25 August 2025
- Published by Wiley in Liver International
- Vol. 45 (9) , e70305
Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications
Background and Aims: Metabolic dysfunction‐associated steatotic liver disease (MASLD) has become the leading cause of chronic liver disease worldwide. Metabolic syndrome (MetS) has traditionally been used as an indicator to define metabolic dysfunction, but it may not fully reflect the risk spectrum of MASLD, underscoring the need to better understand its clinical heterogeneity. The aim of this study was to explore phenotypic heterogeneity within MASLD, in particular its overlap and divergence from MetS to improve clinical stratification. Methods: We applied an unsupervised clustering approach in a discovery cohort of 600 adults recruited through a local health screening programme, using standardised clinical and metabolic variables to identify distinct phenotypes. Associations between clustering, MASLD and MetS were assessed. External validation was performed on an independent cohort of 407 individuals using cluster centroids derived from the discovery cohort. Results: In the two‐cluster model, we identified a low‐risk group with favourable profiles and a high‐risk group enriched for MASLD and MetS. The three‐cluster model further refined these patterns, revealing an intermediate group characterised by MASLD without MetS, with heterogeneous yet clinically relevant metabolic features. Cluster structures were preserved in the validation cohort. Cluster membership was significantly associated with steatosis and liver fibrosis parameters. Conclusions: Our findings underscore the phenotypic heterogeneity of MASLD and its partial divergence from MetS. As MetS may not fully capture the spectrum of metabolic dysfunction in MASLD, phenotype‐based approaches grounded in clinical and metabolic data may enhance risk stratification and support more individualised management strategies.
- 25 August 2025
- Published by Wiley in Liver International
- Vol. 45 (9) , e70305
Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications
Background and Aims: Metabolic dysfunction‐associated steatotic liver disease (MASLD) has become the leading cause of chronic liver disease worldwide. Metabolic syndrome (MetS) has traditionally been used as an indicator to define metabolic dysfunction, but it may not fully reflect the risk spectrum of MASLD, underscoring the need to better understand its clinical heterogeneity. The aim of this study was to explore phenotypic heterogeneity within MASLD, in particular its overlap and divergence from MetS to improve clinical stratification. Methods: We applied an unsupervised clustering approach in a discovery cohort of 600 adults recruited through a local health screening programme, using standardised clinical and metabolic variables to identify distinct phenotypes. Associations between clustering, MASLD and MetS were assessed. External validation was performed on an independent cohort of 407 individuals using cluster centroids derived from the discovery cohort. Results: In the two‐cluster model, we identified a low‐risk group with favourable profiles and a high‐risk group enriched for MASLD and MetS. The three‐cluster model further refined these patterns, revealing an intermediate group characterised by MASLD without MetS, with heterogeneous yet clinically relevant metabolic features. Cluster structures were preserved in the validation cohort. Cluster membership was significantly associated with steatosis and liver fibrosis parameters. Conclusions: Our findings underscore the phenotypic heterogeneity of MASLD and its partial divergence from MetS. As MetS may not fully capture the spectrum of metabolic dysfunction in MASLD, phenotype‐based approaches grounded in clinical and metabolic data may enhance risk stratification and support more individualised management strategies.
- Open Access
- 18 September 2021
- Published by Wiley in Journal of Addiction
- Vol. 2021, 1-7
High Frequency and Low Intensity Transcranial Magnetic Stimulation for Smoking Cessation
Introduction. Tobacco consumption is one of the main causes of mortality in the world. Because of its effect on health, smoking cessation should be prioritized as an important health intervention; however, current interventions have shown low success rates as only 31 of the cases can stop smoking. In this paper, an intervention with high frequency and low intensity transcranial magnetic stimulation (HFLI TMS) was applied to determine if this type of neuromodulation could have an effect in decreasing tobacco addiction. Methods. Retrospective data from ten ambulatory smoker patients that underwent 24 sessions of HFLI TMS over 8 weeks were retrieved and are here presented. Results. Exhaled CO concentrations were statistically significantly different from baseline at the weeks 3, 5, 6, and 8. After the 24 sessions, all patients stopped smoking; this was confirmed directly by exhaled carbon monoxide and the smoking diary. Three months after intervention, eight out of ten subjects continued without smoking. No severe adverse effects were reported by participants. Conclusions. Overall, employing HFLI TMS appears to have acceptable result; however, further evidence is needed to determine with more certainty its therapeutic effect and adverse effects for addiction intervention.
- 18 September 2021
- Published by Wiley in Journal of Addiction
- Vol. 2021, 1-7
Open AccessHigh Frequency and Low Intensity Transcranial Magnetic Stimulation for Smoking Cessation
Introduction. Tobacco consumption is one of the main causes of mortality in the world. Because of its effect on health, smoking cessation should be prioritized as an important health intervention; however, current interventions have shown low success rates as only 31 of the cases can stop smoking. In this paper, an intervention with high frequency and low intensity transcranial magnetic stimulation (HFLI TMS) was applied to determine if this type of neuromodulation could have an effect in decreasing tobacco addiction. Methods. Retrospective data from ten ambulatory smoker patients that underwent 24 sessions of HFLI TMS over 8 weeks were retrieved and are here presented. Results. Exhaled CO concentrations were statistically significantly different from baseline at the weeks 3, 5, 6, and 8. After the 24 sessions, all patients stopped smoking; this was confirmed directly by exhaled carbon monoxide and the smoking diary. Three months after intervention, eight out of ten subjects continued without smoking. No severe adverse effects were reported by participants. Conclusions. Overall, employing HFLI TMS appears to have acceptable result; however, further evidence is needed to determine with more certainty its therapeutic effect and adverse effects for addiction intervention.
- Open Access
- 13 April 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (8) , 4079
Lung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review
The tobacco industry promotes electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP) as a safer alternative to conventional cigarettes with misleading marketing sustained by studies with conflict of interest. As a result, these devices sell without regulations and warnings about their adverse effects on health, with a growing user base targeting young people. This systematic review aimed to describe the adverse effects on the respiratory system in consumers of these devices. We conducted a systematic review and bibliometric analysis of 79 studies without conflict of interest evaluating ENDS and HTP effects in the respiratory system in experimental models, retrieved from the PubMed database. We found that the damage produced by using these devices is involved in pathways related to pulmonary diseases, involving mechanisms previously reported in conventional cigarettes as well as new mechanisms particular to these devices, which challenges that the tobacco industry’s claims. The present study provides significant evidence to suggest that these devices are an emerging public health problem and that they should be regulated or avoided.
- 13 April 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (8) , 4079
Open AccessLung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review
The tobacco industry promotes electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP) as a safer alternative to conventional cigarettes with misleading marketing sustained by studies with conflict of interest. As a result, these devices sell without regulations and warnings about their adverse effects on health, with a growing user base targeting young people. This systematic review aimed to describe the adverse effects on the respiratory system in consumers of these devices. We conducted a systematic review and bibliometric analysis of 79 studies without conflict of interest evaluating ENDS and HTP effects in the respiratory system in experimental models, retrieved from the PubMed database. We found that the damage produced by using these devices is involved in pathways related to pulmonary diseases, involving mechanisms previously reported in conventional cigarettes as well as new mechanisms particular to these devices, which challenges that the tobacco industry’s claims. The present study provides significant evidence to suggest that these devices are an emerging public health problem and that they should be regulated or avoided.
- 10 October 2020
- Published by Universidad Nacional Autonoma de Mexico in Revista de la Facultad de Medicina
- Vol. 63 (6) , 7-19
Efectos en la salud de los sistemas electrónicos de administración de nicotina (SEAN)
Without a doubt, smoking continues to be the leading cause of disease, disability, and premature death worldwide. How ever, the advent of the new Electronic Administration Systems of Nicotine (SEAN), among which the electronic cigarette stands out, has had explosive growth and in some countries has depleted tobacco cigarettes, especially among young people who feel attracted by its striking flavors and the deployment of technology that is used in its design and operation. The SEANs initially emerged in 2003 as a supposed help to quit smoking, at 16 years from this date no clinical studies are confirming their superiority over existing medications for this purpose: nicotine, bupropion and varenicline replacement therapies, or over psychological therapies such as emotional and cognitive-behavioral rational. On the other side, a large amount of evidence has been accumulated on the deleterious effect they have on the health of consumers, the risk they represent is unquestionable and this is confirmed by recent reports from the Centers for Disease Control of the United States (CDC) that indicate 2142 hospitalized cases with acute lung disease and 42 deaths from this cause, 79% being people under 35 years. This outbreak of lung disease has determined that the ban on SEAN in the United States will be planted. Also, the Food and Drug Administration (FDA) approved the sale of hybrid cigarettes or “Heets” (Heat-not-burn tobacco products), which uses heated tobacco, and are now available in our country. There is no doubt that as health professionals, we must inform with scientific evidence about the risks that SEANs pose to their consumers, we must also learn from the history of smoking to prevent the morbidity and mortality associated with these new tobacco products. Keywords: Electronic nicotine delivery systems (ENDS); electronic cigarettes; JUUL®; heets; toxicity; health effects; damage.
- 10 October 2020
- Published by Universidad Nacional Autonoma de Mexico in Revista de la Facultad de Medicina
- Vol. 63 (6) , 7-19
Efectos en la salud de los sistemas electrónicos de administración de nicotina (SEAN)
Without a doubt, smoking continues to be the leading cause of disease, disability, and premature death worldwide. How ever, the advent of the new Electronic Administration Systems of Nicotine (SEAN), among which the electronic cigarette stands out, has had explosive growth and in some countries has depleted tobacco cigarettes, especially among young people who feel attracted by its striking flavors and the deployment of technology that is used in its design and operation. The SEANs initially emerged in 2003 as a supposed help to quit smoking, at 16 years from this date no clinical studies are confirming their superiority over existing medications for this purpose: nicotine, bupropion and varenicline replacement therapies, or over psychological therapies such as emotional and cognitive-behavioral rational. On the other side, a large amount of evidence has been accumulated on the deleterious effect they have on the health of consumers, the risk they represent is unquestionable and this is confirmed by recent reports from the Centers for Disease Control of the United States (CDC) that indicate 2142 hospitalized cases with acute lung disease and 42 deaths from this cause, 79% being people under 35 years. This outbreak of lung disease has determined that the ban on SEAN in the United States will be planted. Also, the Food and Drug Administration (FDA) approved the sale of hybrid cigarettes or “Heets” (Heat-not-burn tobacco products), which uses heated tobacco, and are now available in our country. There is no doubt that as health professionals, we must inform with scientific evidence about the risks that SEANs pose to their consumers, we must also learn from the history of smoking to prevent the morbidity and mortality associated with these new tobacco products. Keywords: Electronic nicotine delivery systems (ENDS); electronic cigarettes; JUUL®; heets; toxicity; health effects; damage.
- 24 August 2020
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 43 (1) , 221-234
Indoor radon exposure and excess of lung cancer mortality: the case of Mexico—an ecological study
Radon is a radioactive gas that can migrate from soils and rocks and accumulate in indoor areas such as dwellings and buildings. Many studies have shown a strong association between the exposure to radon, and its decay products, and lung cancer (LC), particularly in miners. In Mexico, according to published surveys, there is evidence of radon exposure in large groups of the population, nevertheless, only few attention has been paid to its association as a risk factor for LC. The aim of this ecological study is to evaluate the excess risk of lung cancer mortality in Mexico due to indoor radon exposure. Mean radon levels per state of the Country were obtained from different publications and lung cancer mortality was obtained from the National Institute of Statistics, Geography and Informatics for the period 2001–2013. A model proposed by the International Commission on Radiological Protection to estimate the annual excess risk of LC mortality (per 105 inhabitants) per dose unit of radon was used. The average indoor radon concentrations found rank from 51 to 1863 Bq m−3, the higher average dose exposure found was 3.13 mSv year−1 in the north of the country (Chihuahua) and the mortality excess of LC cases found in the country was 10 ± 1.5 (range 1–235 deaths) per 105 inhabitants. The highest values were found mainly in the Northern part of the country, where numerous uranium deposits are found, followed by Mexico City, the most crowded and most air polluted area in the country. A positive correlation (r = 0.98 p < 0.0001) was found between the excess of LC cases and the dose of radon exposure. Although the excess risk of LC mortality associated with indoor radon found in this study was relatively low, further studies are needed in order to accurately establish its magnitude in the country.
- 24 August 2020
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 43 (1) , 221-234
Indoor radon exposure and excess of lung cancer mortality: the case of Mexico—an ecological study
Radon is a radioactive gas that can migrate from soils and rocks and accumulate in indoor areas such as dwellings and buildings. Many studies have shown a strong association between the exposure to radon, and its decay products, and lung cancer (LC), particularly in miners. In Mexico, according to published surveys, there is evidence of radon exposure in large groups of the population, nevertheless, only few attention has been paid to its association as a risk factor for LC. The aim of this ecological study is to evaluate the excess risk of lung cancer mortality in Mexico due to indoor radon exposure. Mean radon levels per state of the Country were obtained from different publications and lung cancer mortality was obtained from the National Institute of Statistics, Geography and Informatics for the period 2001–2013. A model proposed by the International Commission on Radiological Protection to estimate the annual excess risk of LC mortality (per 105 inhabitants) per dose unit of radon was used. The average indoor radon concentrations found rank from 51 to 1863 Bq m−3, the higher average dose exposure found was 3.13 mSv year−1 in the north of the country (Chihuahua) and the mortality excess of LC cases found in the country was 10 ± 1.5 (range 1–235 deaths) per 105 inhabitants. The highest values were found mainly in the Northern part of the country, where numerous uranium deposits are found, followed by Mexico City, the most crowded and most air polluted area in the country. A positive correlation (r = 0.98 p < 0.0001) was found between the excess of LC cases and the dose of radon exposure. Although the excess risk of LC mortality associated with indoor radon found in this study was relatively low, further studies are needed in order to accurately establish its magnitude in the country.
- 11 May 2020
- Published by Universidad Nacional Autonoma de Mexico in Revista Digital Universitaria
- Vol. 21 (3)
El cigarrillo electrónico. Mitos y realidades. Segunda parte
Recientemente se ha presentado un crecimiento explosivo de consumidores de los Sistemas Electrónicos de Administración de Nicotina (sean), entre los cuales los cigarrillos electrónicos son los más comunes. Al principio, su uso se recomendaba para dejar de fumar, pero actualmente se han consolidado como una vía a través de la que niños y adolescentes se inician en la adicción a la nicotina. Asimismo, muchos adultos fumadores de cigarrillos de tabaco también los consumen, creando lo que se conoce como “fumador dual”. Lo peor es que son el vehículo para la inhalación de aceite de Cannabis, vitaminas liposolubles como la E, múltiples colorantes, saborizantes y aceites esenciales, además de drogas como el fentanilo. Se cuenta con un gran número de evidencias clínicas y epidemiológicas de los efectos adversos que pueden generar los sean: daño pulmonar agudo, inflamación de garganta, tos seca, infecciones virales. A largo plazo su empleo incrementa el riesgo de Enfermedad Pulmonar Obstructiva Crónica (epoc) e infartos al miocardio. Aunado a esto, la tercera generación de sean cuenta con pilas de más alto voltaje, que tienen mayor probabilidad de explotar, provocando daños graves como fracturas, quemaduras y pérdida de falanges. Es urgente que los consumidores conozcan los riesgos asociados al uso de vapeadores para poder tomar una decisión informada. En este artículo presentamos datos al respecto, basados en evidencias científicas.
- 11 May 2020
- Published by Universidad Nacional Autonoma de Mexico in Revista Digital Universitaria
- Vol. 21 (3)
El cigarrillo electrónico. Mitos y realidades. Segunda parte
Recientemente se ha presentado un crecimiento explosivo de consumidores de los Sistemas Electrónicos de Administración de Nicotina (sean), entre los cuales los cigarrillos electrónicos son los más comunes. Al principio, su uso se recomendaba para dejar de fumar, pero actualmente se han consolidado como una vía a través de la que niños y adolescentes se inician en la adicción a la nicotina. Asimismo, muchos adultos fumadores de cigarrillos de tabaco también los consumen, creando lo que se conoce como “fumador dual”. Lo peor es que son el vehículo para la inhalación de aceite de Cannabis, vitaminas liposolubles como la E, múltiples colorantes, saborizantes y aceites esenciales, además de drogas como el fentanilo. Se cuenta con un gran número de evidencias clínicas y epidemiológicas de los efectos adversos que pueden generar los sean: daño pulmonar agudo, inflamación de garganta, tos seca, infecciones virales. A largo plazo su empleo incrementa el riesgo de Enfermedad Pulmonar Obstructiva Crónica (epoc) e infartos al miocardio. Aunado a esto, la tercera generación de sean cuenta con pilas de más alto voltaje, que tienen mayor probabilidad de explotar, provocando daños graves como fracturas, quemaduras y pérdida de falanges. Es urgente que los consumidores conozcan los riesgos asociados al uso de vapeadores para poder tomar una decisión informada. En este artículo presentamos datos al respecto, basados en evidencias científicas.